A new ruling on the ACA adds more uncertainty about the law’s future.
A recent study suggests healthcare organizations see reimbursement concerns—as well as differences in business culture – as roadblocks to embracing digital health partnerships.
Could per-person adjustments to Medicaid payments help better address social inequalities that affect overall health?
CMS has put forth pricing transparency provisions for both hospitals and insurers – but what will they really mean for healthcare?
As more healthcare organizations look to curb hospital readmission rates, they are taking a hard look at one of medicine’s most complex conditions—cancer.
Healthcare is still undergoing a large number of M&As – but are they offering the kind of value originally sought? New research suggests not.
How can payers appropriately plan and manage benefit coverage with so many expensive specialty drugs coming down the pipeline?
As more biosimilar drugs gain approval, managed care organizations need to consider how to best utilize them for optimal savings.
As more of the healthcare industry moves to value-based contracts, it is imperative that managed care organizations can successfully measure outcomes.
With the proposed rebate rule now withdrawn, what will Congress do to help curb drug spend?